Deepak Nair, MD
Vascular Surgery · University Park, FLNPI 1841491495
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $16,988 of the $19,616 with a category attached, or 86.6%. It is spread thinly across 33 manufacturers, the largest accounting for just 22.9% — the pattern of someone who eats at a lot of different presentations.
Across 328 payments — averaging $59.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- W. L. Gore & Associates, Inc.$3K
- Angiodynamics, Inc.$2K
- Cook Medical LLC$2K
- Silk Road Medical, Inc.$1K
- Abbott$1K
- plus $5K from 27 others
Across 10 payments — averaging $3082.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$31K
What the payments were for
- Travel & lodging$1331%
- Food & beverage$16,98887%
- Education$700%
- Other$2,42412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 90 | $4,489 |
| W. L. Gore & Associates, Inc. | 39 | $2,877 |
| Angiodynamics, Inc. | 7 | $2,484 |
| Cook Medical LLC | 41 | $2,396 |
| Silk Road Medical, Inc. | 25 | $1,415 |
| Abbott | 19 | $1,413 |
| Philips North America LLC | 14 | $731 |
| Johnson & Johnson | 24 | $629 |
| Penumbra, Inc. | 8 | $610 |
| Terumo Medical Corporation | 5 | $508 |
| Boston Scientific | 8 | $319 |
| Bard Peripheral Vascular, Inc. | 4 | $295 |
| Arthrex | 3 | $202 |
| Stryker | 1 | $147 |
| Smith+Nephew | 7 | $141 |
| Organogenesis Inc. | 2 | $137 |
| Kerecis Limited | 2 | $131 |
| Cardiva Medical, Inc. | 2 | $101 |
| Venclose Inc. | 1 | $98 |
| Getinge USA Sales, LLC | 4 | $87 |
| Cardinal Health 200 LLC | 1 | $81 |
| Solventum Corporation | 2 | $42 |
| UCB, Inc. | 2 | $41 |
| Inari Medical, Inc. | 3 | $41 |
| Cvrx, Inc. | 2 | $36 |
| Convatec Inc. | 1 | $33 |
| Cashflow Solutions, LLC | 4 | $29 |
| Biocompatibles, Inc. | 2 | $29 |
| Tactile Systems Technology Inc | 1 | $23 |
| AstraZeneca | 1 | $20 |
| Catheter Precision, Inc. FKA Ra Medical Systems, Inc. | 1 | $13 |
| Avenu Medical Inc. | 1 | $12 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VenaCure 1470 Pro$2,400
- ENDURANT IIS$1,908
- ENROUTE Transcarotid Neuroprotection System$1,245
- ENROUTE Transcarotid Stent$912
- Zilver PTX$738
- GORE VIABAHN VBX Balloon Expandable Endo$573
- Endurant$483
- Kerecis Omega3 Marigen$470
- Cook Medical Zilver PTX$385
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$334
- GORE EXCLUDER Iliac Branch Endoprosthesis$334
- Indigo System$269
- ESPRIT$257
- Azur CX Detachable$249
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$245
- XARELTO$236
- Conformable TAG Thoracic Endoprosthesis$179
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$168
- ENROUTE Transcarotid Stent System$165
- ENHANCE Transcarotid Peripheral Access Kit$165
How this compares
$19,616 in reported general payments places this provider in the 80th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 75 | $84,442 |
| EliquisApixaban | 80 | $68,037 |
| ClopidogrelClopidogrel Bisulfate | 297 | $3,223 |
| Cilostazol | 63 | $1,654 |
| Hydrochlorothiazide | 78 | $287 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $158 |
| Methylprednisolone | 13 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $629 | $84,44275 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 385 vascular surgery providers in Florida.
Other vascular surgery in University Park
- Samuel TapperStuart$1.3M
- Mariano ArosemenaBradenton$472K
- Manuel Perez IzquierdoOrlando$302K
- Erin MooreJacksonville$300K
- Rajesh MalikNaples$237K
- Charles BaileyTampa$162K
- Joseph WasselleMelbourne$161K
- Joseph RicottaDelray Beach$156K
- Murray ShamesTampa$144K
- K Dean ArnaoutakisTampa$115K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.